Periocular Amyloidosis Manifesting as Pseudopemphigoid Treated With Mitomycin C. Issue 4 (April 2017)

• Record Type: Journal Article
• Authors: Vahdani, Kaveh; Thaller, Vladimir T.; Albanese, Giorgio; Dean, Andrew F.
• Is Part Of: Cornea. Volume 36:Issue 4(2017)
• Publication Date: 2017-04
• Subjects: amyloidosis -- periocular amyloid -- pemphigoid -- pseudopemphigoid -- mitomycin C; Cornea -- Periodicals; Cornea -- Periodicals; Cornée -- Périodiques; 617.719
• DOI: 10.1097/ICO.0000000000001138
• Languages: English
• ISSNs: 0277-3740

Abstract

Abstract : Purpose: To describe an unusual cicatrizing manifestation of periocular amyloid and the utility of adjuvant antimetabolite therapy. Methods: This is a case report of a 49-year old woman with progressive bilateral upper lid ptosis, who was found to have bilateral inferior forniceal masses with thickening of the conjunctiva. Conjunctival and eyelid biopsies showed evidence of amyloid deposition. Systemic evaluation did not reveal any evidence of systemic amyloidosis. Her blepharoptosis continued to deteriorate, and she underwent bilateral sequential upper lid ptosis correction surgery and debulking procedures. Subsequently, she developed severe and progressive cicatricial conjunctivitis with extensive symblepharon formation in all 4 fornices and restriction of ocular motility, simulating a clinical picture of ocular mucous membrane pemphigoid. Results: She was treated surgically by division of symblepharon augmented with application of topical mitomycin C intraoperatively. This has been partially successful in freeing up differential movement between her lid and her eye and consequently improving eye protection and lubrication. Conclusions: Pseudopemphigoid represents a rare manifestation of periocular amyloid. Risks and benefits of surgical procedures in this context need to be carefully weighed to minimize the risk of secondary complications. Topical mitomycin C may be considered as a relatively safe adjunct in managing the cicatricial component of the disease.